Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577798 · ClinicalTrials.gov registry record
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 10
- Enrollment target
NCT00577798 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 10 participants.
The verdict
NCT00577798 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as cardiac magnetic resonance imaging, may help doctors detect early changes in the heart caused by chemotherapy. PURPOSE: This clinical trial is studying how well cardiac magnetic resonance imaging works in patients with newly diagnosed non-Hodgkin lymphoma or Hodgkin lymphoma receiving doxorubicin.
Interventions
- PROCEDURE contrast-enhanced magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-01-01 |
| Est. Completion | 2013-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577798
The ClinicalTrials.gov registry entry for NCT00577798 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which contrast-enhanced magnetic resonance imaging is the first listed.
NCT00577798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577798 about?
NCT00577798 is a clinical study titled "Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin". RATIONALE: Diagnostic procedures, such as cardiac magnetic resonance imaging, may help doctors detect early changes in the heart caused by chemotherapy. PURPOSE: This clinical trial is studying how well cardiac magnetic resonance imaging works in patients with newly diagnosed non-Hodgkin lymphoma o...
What is the current status of trial NCT00577798?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-01-01. Estimated completion is 2013-02-01.
What interventions are being tested in trial NCT00577798?
The interventions under investigation include: contrast-enhanced magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00577798?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.